Back to search results

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

Abroad (travel likely)RecruitingPHASE2

Conditions

Cognitive Dysfunction · Lewy Body Disease · Synucleinopathies · Amyloid

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • TrialSphere Corp, Chandler, Arizona, United States

    Study coordinator · 480-508-1038
    Contact: Principal Investigator (Hemant Pandey)

  • HonorHealth Research Institute, Scottsdale, Arizona, United States

    Contact: Principal Investigator (Todd Levine)

  • Profound Research LLC, Carlsbad, California, United States

    Study coordinator · 760-631-3000
    Contact: Principal Investigator (Benjamin Frishberg)

  • Irvine Clinical Research, Irvine, California, United States

    Study coordinator · 949-753-1663
    Contact: Principal Investigator (Edward Zamrini)

  • UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla, California, United States

    Contact: Principal Investigator (Stephanie Lessig)

  • Stanford Neuroscience Health Center, Palo Alto, California, United States

    Study coordinator · 818-398-9855
    Contact: Principal Investigator (Irina Skylar-Scott)

  • CenExel Rocky Mountain Clinical Research, Englewood, Colorado, United States

    Contact: Principal Investigator (Meagen Salinas)

  • Ki Health Partners, LLc, dba New England Institute for Clinical Research, Stamford, Connecticut, United States

    Study coordinator · 203-914-1903
    Contact: Principal Investigator (Peter McAllister)

  • JEM Research Institute, Atlantis, Florida, United States

    Study coordinator · 561-968-2933
    Contact: Principal Investigator (Linda Pao)

  • VIN - Aventura, Aventura, Florida, United States

    Study coordinator · 305-933-5993
    Contact: Principal Investigator (Jonathan Cross)

  • Brain Matters Research, Delray Beach, Florida, United States

    Study coordinator · 561-374-8461
    Contact: Principal Investigator (Paayal Patel)

  • Neuropsychiatric Research Center of Southwest Florida, Fort Myers, Florida, United States

    Study coordinator · 239-939-7777
    Contact: Principal Investigator (John Huffaker)

  • Norman Fixel Institute for Neurological Diseases (FIND), Gainesville, Florida, United States

    Contact: Principal Investigator (Bhavana Patel)

  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Principal Investigator (Neill Graff-Radford)

  • K2 Medical Research ORLANDO, Maitland, Florida, United States

    Study coordinator · 407-500-5252
    Contact: Principal Investigator (Sheila Baez-Torres)

  • BRP-Kendal Lakes, Miami, Florida, United States

    Contact: Principal Investigator (Jose Gonzalez)

  • Renstar Medical Research, Ocala, Florida, United States

    Study coordinator · 352-629-5800
    Contact: Principal Investigator (Anette Nieves)

  • Charter Research - Orlando, Orlando, Florida, United States

    Study coordinator · 407-337-1000
    Contact: Principal Investigator (Diana Balsalobre)

  • Axiom Brain Health LLC, Tampa, Florida, United States

    Study coordinator · 813-353-9613
    Contact: Principal Investigator (Susan Steen)

  • Palm Beach Neurology, West Palm Beach, Florida, United States

    Study coordinator · 561-845-0500
    Contact: Principal Investigator (Paul Winner)

  • Conquest Research, Winter Park, Florida, United States

    Study coordinator · 407-916-0060
    Contact: Principal Investigator (Malisa Agard)

  • Indiana University Health Neuroscience Center, Indianapolis, Indiana, United States

    Study coordinator · 317-963-7402
    Contact: Principal Investigator (Jared Brosch)

  • The University of Kansas - Clinical Research Center, Fairway, Kansas, United States

    Study coordinator · 913-574-0976
    Contact: Principal Investigator (Ryan Townley)

  • Massachusetts General Hospital - Charlestown, Charlestown, Massachusetts, United States

    Contact: Principal Investigator (Anna Goodheart)

  • K2 Medical Research - Foxborough, Foxborough, Massachusetts, United States

    Study coordinator · 401-435-8950
    Contact: Principal Investigator (john stoukides)

  • Neurology Center of New England, Foxborough, Massachusetts, United States

    Study coordinator · 781-551-5812
    Contact: Principal Investigator (Salvatore Napoli)

  • Headlands Eastern MA LLC, Plymouth, Massachusetts, United States

    Study coordinator · 978-831-8041
    Contact: Principal Investigator (Kinan Hreib)

  • QUEST Research Institute, Farmington Hills, Michigan, United States

    Study coordinator · 248-957-8940
    Contact: Principal Investigator (Aaron Ellenbogen)

  • Struthers Parkinson's Center, Golden Valley, Minnesota, United States

    Contact: Principal Investigator (Sotirios Parashos)

  • Mayo Clinic in Rochester, Minnesota, Rochester, Minnesota, United States

    Contact: Principal Investigator (Jonathan Graff-Radford)

  • Citizens Memorial Hospital District, Bolivar, Missouri, United States

    Study coordinator · 417-328-7781
    Contact: Principal Investigator (Curtis Schreiber)

  • Summit Headlands, Portland, Oregon, United States

    Study coordinator · 503-279-8252
    Contact: Principal Investigator (Scott Losk)

  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Principal Investigator (Aimee Pierce)

  • Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

    Contact: Principal Investigator (Rebecca Williamson)

  • Gadolin Research, Beaumont, Texas, United States

    Study coordinator · 409-331-6040
    Contact: Principal Investigator (Kandasami Senthilkumar)

  • Kerwin Medical Center, Dallas, Texas, United States

    Contact: Principal Investigator (Alka Khera)

  • Houston Methodist Hospital, Houston, Texas, United States

    Contact: Principal Investigator (Juan Toledo Atucha)

  • The University of Texas Health Science Center at Houston, Houston, Texas, United States

    Study coordinator · 713-486-0536
    Contact: Principal Investigator (David Hunter)

  • Central Texas Neurology Consultants, Round Rock, Texas, United States

    Study coordinator · 512-218-1222
    Contact: Principal Investigator (Elizabeth Peckham)

  • The University of Texas Health Science Center, San Antonio, Texas, United States

    Contact: Principal Investigator (Sudha Seshadri)

  • Re:Cognition Health, Fairfax, Virginia, United States

    Study coordinator · 703-520-9703
    Contact: Principal Investigator (Raymond Turner)

  • EvergreenHealth, Kirkland, Washington, United States

    Study coordinator · 425-899-5385
    Contact: Principal Investigator (Pinky Agarwal)

  • Memory Clinic Ochanomizu, Bunkyō City, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Takashi Asada)

  • Shonan Keiiku Hospital, Fujisawa, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Yasuo Terayama)

  • Hyogo Prefectural Harima-Himeji General Medical Center, Himeji, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Kenichi Shimada)

  • Inage Neurology and Memory Clinic, Inage, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Yasumasa Yoshiyama)

  • Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Kentaro Suzuki)

  • St. Marianna University Hospital, Kawasaki, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Koji Kasanuki)

  • Kobe University Hospital, Kobe, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Hisatomo Kowa)

  • Juntendo Tokyo Koto Geriatric Medical Center, Kōtoku, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Kenya Nishioka)

  • Katayama Medical Clinic, Kurashiki, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Sadao Katayama)

  • Nagoya Ekisaikai Hospital, Nagoya, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Tomotsugu Kaga)

  • Nagoya University Hospital, Nagoya, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Masahisa Katsuno)

  • National Center for Geriatrics and Gerontology, Ōbu, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Kazunori Imai)

  • The University of Osaka Hospital, Suita, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Yuto Satake)

  • Tokyo Metropolitan Institute for Geriatrics and Gerontology, tabashi City, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Atsushi Iwata)

  • Tachikawa Hospital, Tachikawa, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Hidenori Hattori)

  • Memory Clinic Toride, Toride, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Youshun Boku)

  • Yokohama Minami Kyosai Hospital, Yokohama, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Shigeru Koyano)

  • Oita University Hospital, Yufu, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Noriyuki Kimura)

  • Gangnam Severance Hospital, Yonsei University Health System, Gangnam-gu, South Korea

    Study coordinator · +82-10-3000-4975
    Contact: Principal Investigator (Hanna Cho)

  • Inha University Hospital, Incheon, South Korea

    Contact: Principal Investigator (Seong Hye Choi)

  • Severance Hospital, Yonsei University Health System, Seoul, South Korea

    Study coordinator · 82-10-2505-9280
    Contact: Principal Investigator (Byoung Seok Ye)

  • Hanyang University Seoul Hospital, Seoul, South Korea

    Study coordinator · 82-2-2290-8374
    Contact: Principal Investigator (Hee-Jin Kim)

  • Konkuk University Medical Center, Seoul, South Korea

    Contact: Principal Investigator (Seol-Heui Han)

  • Ewha Womans University Mokdong Hospital, Seoul, South Korea

    Contact: Principal Investigator (Geon Ha Kim)

  • Taipei Medical University Shuang Ho Hospital, New Taipei City, Taiwan

    Study coordinator · 02224900888819
    Contact: Principal Investigator (Chaur-Jong Hu)

  • New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan

    Study coordinator · 03-3281200
    Contact: Principal Investigator (Jung Lung Hsu)

  • National Cheng Kung University Hospital, Tainan, Taiwan

    Study coordinator · 886 972401434
    Contact: Principal Investigator (MingChyi Pai)

  • National Taiwan University Hospital, Taipei, Taiwan

    Contact: Principal Investigator (Cheng-Hsuan Li)

  • Taipei Veterans General Hospital, Taipei, Taiwan

    Study coordinator · 886228757578
    Contact: Principal Investigator (Jong-Ling Fuh)

  • Chang Gung Medical Foundation-Linkou Branch, Taoyuan, Taiwan

    Contact: Principal Investigator (WEI-MIN HO)
Study leads

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

View source on ClinicalTrials.gov(opens in a new tab)